49 results
Page 3 of 3
424B5
u1d368
4 Apr 19
Prospectus supplement for primary offering
4:13pm
8-K
EX-10.1
hmzo2ihv pqu0
11 Jan 19
Entry into a Material Definitive Agreement
5:02pm
8-K
EX-99.1
iksv45yz
3 Dec 18
Syros Announces Promising Clinical Data from Ongoing Phase 2 Trial of SY-1425 in Genomically Defined AML and MDS Patients at ASH Annual Meeting
8:07am
8-K
EX-99.1
21nor9w
15 Nov 18
Regulation FD Disclosure
4:03pm
10-K
4tylq21 5t
20 Mar 17
Annual report
12:00am